A client receiving tezepelumab for severe asthma develops acute wheezing, accessory-muscle use, and difficulty speaking. Which action is best?

1 Use the scheduled tezepelumab injection as the only rescue treatment and wait for it to reverse the bronchospasm.
2 Stop inhaled and systemic corticosteroids immediately because biologic therapy now replaces both.
3 Delay respiratory assessment and wait for the next scheduled biologic appointment before using rescue therapy.
4 Activate the prescribed acute-asthma rescue plan and urgent assessment; tezepelumab is not a rescue drug. ✓ Correct answer

Explanation

Tezepelumab is maintenance treatment and does not treat acute bronchospasm or status asthmaticus. Acute respiratory distress requires rescue therapy and urgent assessment.

Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Do not substitute maintenance biologic therapy for acute asthma rescue.

Why this is correct
Corticosteroids also should not be stopped abruptly when tezepelumab begins; any reduction is gradual and supervised.

Easy analogy or mental picture
Use a closed medication-safety loop: identify the immune or cytotoxic exposure, connect the new findings, interrupt further harm, stabilize the client, and verify the response over time.

Memory hook
Exposure, immune effect, organ toxicity, infection risk, immediate action, and serial reassessment.

NCLEX decision rule
Choose the action that reduces the most immediate medication-related risk while preserving diagnostic evaluation and authorized treatment.

Why the other choices are wrong
Options that continue the exposure, treat only one symptom, or delay reassessment leave the toxic or infectious process active.

References

1DailyMed: TEZSPIRE (tezepelumab)Maintenance treatment, no role in acute bronchospasm, gradual corticosteroid reduction, helminth infection, and live-vaccine avoidance

Clinical scenario

Oncology, transplant, and biologic safety review
Verify the indication, immune status, infection screen, interacting medicines, current organ findings, authorized action, and measurable follow-up.

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

A client receiving tezepelumab for severe asthma develops acute wheezing, accessory-muscle use, and difficulty speaking. Which action is best?

In-depth explanation

Clinical scenario

Master the NCLEX-RN with MyMerci